Gilead Sciences Archives - Page 4 of 7 - Express Pharma

Pfizer signs agreement with Gilead Sciences to manufacture remdesivir

Gilead says remdesivir reduced risk of death in Covid-19 patients, more studies needed

Gilead begins testing inhalable form of remdesivir for COVID-19

Gilead prices COVID-19 drug remdesivir at $2,340 per patient in developed nations

Gilead to buy 49.9 per cent stake in cancer drug developer for $275 million

Cipla to price remdesivir version for COVID-19 under 5,000 rupees

Gilead targets remdesivir supply for two million COVID-19 patients by year-end

Gilead to commence trials of inhaled remdesivir

Double digit MCap growth in 2019 for 14 of top 20 pharma companies: GlobalData

Centre clarifies reasons for delay in approvals for remdesivir